Using different methods of bioinformatics, including gene expression difference analysis, survival analysis, gene set enrichment analysis, and tumor-infiltrating immune cell analysis, and combined with histopathological observation, we discovered the diversity between tumor and normal tissues, the relationship between the expression and mutation of CD163, and its effects on the prognosis of CRC patients. Here, CD163 is linked to colorectal carcinoma.